Related Experiment Video
Updated: Feb 17, 2026
06:15
Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
52.2K
European position statement on lung cancer screening
Matthijs Oudkerk1, Anand Devaraj2, Rozemarijn Vliegenthart1
1Center for Medical Imaging, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
The Lancet. Oncology
|December 7, 2017
Summary
Implementing low-dose CT (computed tomography) lung cancer screening across Europe requires a strategic approach. Key actions include risk stratification, patient education, smoking cessation, and standardized nodule management for successful lung cancer screening programs.
Area of Science:
- Pulmonology
- Radiology
- Public Health
Background:
- Low-dose CT (computed tomography) screening offers significant life-saving potential for lung cancer.
- Successful implementation of lung cancer screening programs in Europe faces several challenges.
- A unified European approach is needed to address these challenges.
Purpose of the Study:
- To present evidence and identify critical issues for implementing low-dose CT lung cancer screening in Europe.
- To outline specific actions for the European lung cancer screening community.
- To guide the development of effective lung cancer screening strategies.
Main Methods:
- Review of available evidence on low-dose CT for lung cancer screening.
- Identification of key implementation challenges and required actions.
- Formulation of recommendations for a European position statement.
Main Results:
- Recommends risk stratification for lung cancer screening programs.
- Emphasizes patient information on screening benefits/harms and smoking cessation.
- Advocates for semi-automated measurement of nodules (volume, volume-doubling time) for management.
- Calls for national quality assurance boards and established lung nodule management pathways.
- Specifies management criteria for non-calcified nodules based on volume thresholds.
- Urges immediate planning and timeline setting for European lung cancer screening implementation.
Conclusions:
- A coordinated, evidence-based approach is essential for successful low-dose CT lung cancer screening in Europe.
- Standardized protocols for risk assessment, patient information, nodule management, and quality assurance are crucial.
- Proactive planning and implementation across European countries are urgently needed to realize the benefits of lung cancer screening.
